RxDoctor Payments Data

Morgan Gale

Nurse Practitioner · Rockville, MDNPI 1043730260

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $252,445 of the $291,951 with a category attached, or 86.5%. AbbVie accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $90,873 and has fallen 53.0% since, to $42,676 in 2025. Among nurse practitioner clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$291,951in general payments, 2019–2025

Across 405 payments — averaging $720.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$292K
  • Galderma Laboratories, L.p.$357
  • Merz North America, Inc.$22

What the payments were for

  • Consulting fees$1,0050%
  • Speaking & faculty fees$252,44586%
  • Grants$7,5003%
  • Travel & lodging$24,4378%
  • Food & beverage$6,5642%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)396$291,573
Galderma Laboratories, L.p.8$357
Merz North America, Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$291,951 in reported general payments places this provider in the 95th percentile of 1,562 nurse practitioner providers in Maryland.

See all nurse practitioner providers in Maryland →

Other nurse practitioner in Rockville

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →